CT-4719, also known as 2,4-dichloro-5-methoxyphenoxyethylamine, is a claimed hallucinogen related to psychedelic phenethylamines like mescaline. It is not technically a phenethylamine itself but is a close analogue of this family. The drug was reported to produce behavioral and electrocorticography (ECoG) effects very similar to but twice as potent as those of mescaline in cats. CT-4719 was first described in the scientific literature by 1969. Various related analogues, such as CT-5172 and CT-5126, have also been described. CT-4719 and related compounds were developed at the Laboratoire de Chimie Thérapeutique (CT; Therapeutic Chemistry Laboratory) of the Pasteur Institute in Paris, France.
An analogue of CT-4719 and of mescaline, 3,4,5-trimethoxyphenoxyethylamine, has also been described. "One additional manipulation with some of these structures has been made and should be mentioned. These are the analogues with an oxygen atom inserted between the aromatic ring and the aliphatic chain. They are, in essence, aminoethyl phenyl ethers. The first is related to mescaline itself, 2-(3,4,5-trimethoxyphenoxy)ethylamine. Human trials were conducted over the dose range of 10 to 300 milligrams and there were no effects observed. The second is related to trichocerine, N,N-Dimethyl-2-(3,4,5-trimethoxyphenoxy)ethylamine. It was inactive in man over the range of 10 to 400 milligrams. Mescaline, at a dose of 420 milligrams, served as the control in these studies." It was inactive in terms of psychoactive effects in humans at doses of 10 to 300mg.
See also Phenoxyethylamine ORG-37684
References
External links CT-4719 - Isomer Design